Rob Riemsma

2.4k total citations
51 papers, 1.8k citations indexed

About

Rob Riemsma is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Rob Riemsma has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Hematology. Recurrent topics in Rob Riemsma's work include Rheumatoid Arthritis Research and Therapies (8 papers), Spondyloarthritis Studies and Treatments (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Rob Riemsma is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Spondyloarthritis Studies and Treatments (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Rob Riemsma collaborates with scholars based in United Kingdom, Netherlands and United States. Rob Riemsma's co-authors include Jos Kleijnen, Kate Misso, Kate Light, Nerys Woolacott, Lisa Mather, Zarnie Khadjesari, Gill Worthy, Mark Sculpher, Nigel Armstrong and Neil Hawkins and has published in prestigious journals such as PEDIATRICS, Clinical Psychology Review and British Journal of Cancer.

In The Last Decade

Rob Riemsma

51 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rob Riemsma United Kingdom	22	287	265	244	234	210	51	1.8k
A.M.J. Chorus Netherlands	19	433 1.5×	311 1.2×	165 0.7×	134 0.6×	213 1.0×	47	1.9k
Marja Blom Finland	27	465 1.6×	311 1.2×	158 0.6×	218 0.9×	131 0.6×	55	2.2k
Arthur S. Zbrozek United States	16	358 1.2×	346 1.3×	484 2.0×	217 0.9×	333 1.6×	27	3.3k
Lynda Doward United States	31	732 2.6×	219 0.8×	336 1.4×	400 1.7×	119 0.6×	89	3.0k
Emma Simpson United Kingdom	19	189 0.7×	86 0.3×	221 0.9×	126 0.5×	146 0.7×	47	1.6k
Christopher Ll. Morgan United Kingdom	32	150 0.5×	394 1.5×	398 1.6×	75 0.3×	159 0.8×	80	3.4k
Ed Yelin United States	26	1.0k 3.5×	252 1.0×	172 0.7×	148 0.6×	195 0.9×	50	2.6k
Jennifer H. Lofland United States	23	174 0.6×	164 0.6×	240 1.0×	196 0.8×	160 0.8×	63	1.6k
Paul Swinburn United Kingdom	13	168 0.6×	144 0.5×	209 0.9×	88 0.4×	112 0.5×	30	1.6k
Samuel Whittle Australia	24	662 2.3×	144 0.5×	119 0.5×	177 0.8×	222 1.1×	94	1.6k

Countries citing papers authored by Rob Riemsma

Since Specialization

Citations

This map shows the geographic impact of Rob Riemsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Riemsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Riemsma more than expected).

Fields of papers citing papers by Rob Riemsma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Riemsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Riemsma. The network helps show where Rob Riemsma may publish in the future.

Co-authorship network of co-authors of Rob Riemsma

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Riemsma. A scholar is included among the top collaborators of Rob Riemsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Riemsma. Rob Riemsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grimm, Sabine, Ben Wijnen, Rob Riemsma, et al.. (2021). Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 39(12). 1397–1410. 2 indexed citations

Armstrong, Nigel, Nasuh Büyükkaramikli, Rob Riemsma, et al.. (2020). Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 24(51). 1–220. 13 indexed citations

Grimm, Sabine, Rob Riemsma, Nigel Armstrong, et al.. (2020). Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 39(2). 171–180. 5 indexed citations

Grimm, Sabine, Debra Fayter, Bram Ramaekers, et al.. (2019). Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 37(10). 1195–1207. 8 indexed citations

Grimm, Sabine, Nigel Armstrong, Bram Ramaekers, et al.. (2018). Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 37(5). 655–667. 10 indexed citations

Büyükkaramikli, Nasuh, Saskia de Groot, Rob Riemsma, et al.. (2018). Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 37(2). 141–153. 11 indexed citations

Büyükkaramikli, Nasuh, Hedwig M. Blommestein, Rob Riemsma, et al.. (2017). Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 35(12). 1211–1221. 25 indexed citations

Riemsma, Rob, Maiwenn Al, Isaac Corro Ramos, et al.. (2013). SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 17(61). 1–236. 39 indexed citations

Riemsma, Rob, Carol Forbes, Mayur M. Amonkar, et al.. (2012). Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+ advanced or metastatic breast cancer(MBC). Current Medical Research and Opinion. 28(8). 1263–1279. 18 indexed citations

10.

Riemsma, Rob, Nigel Armstrong, Antoinette D. I. van Asselt, et al.. (2012). Roflumilast for the management of severe chronic obstructive pulmonary disease : A Single Technology Appraisal. University of Groningen research database (University of Groningen / Centre for Information Technology). 1 indexed citations

11.

Wolff, Robert, Kimberly J. Reid, Marcello Di Nisio, et al.. (2012). Systematic Review of Adverse Events of Buprenorphine Patch Versus Fentanyl Patch in Patients with Chronic Moderate-To-Severe Pain. Pain Management. 2(4). 351–362. 20 indexed citations

12.

Bała, Małgorzata M, Trudy Bekkering, Rob Riemsma, et al.. (2011). Epidemiology of chronic pain in the Netherlands. RePub (Erasmus University, Rotterdam). 2 indexed citations

13.

Riemsma, Rob, Carol Forbes, Julie Harker, et al.. (2011). PSY5 A Systematic Review of Tapentadol in Chronic Moderate to Severe Pain. Value in Health. 14(7). A411–A411. 1 indexed citations

14.

McMurran, Mary, Rob Riemsma, Nathan Manning, Kate Misso, & Jos Kleijnen. (2011). Interventions for alcohol-related offending by women: A systematic review. Clinical Psychology Review. 31(6). 909–922. 22 indexed citations

15.

Riemsma, Rob, et al.. (2010). Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer. BMC Cancer. 10(1). 436–436. 40 indexed citations

16.

Schmucker, Christine, Rob Riemsma, Gerd Antes, et al.. (2009). Effectiveness of screening preschool children for amblyopia: a systematic review. BMC Ophthalmology. 9(1). 3–3. 42 indexed citations

17.

Schmucker, Christine, Rob Riemsma, Gerd Antes, et al.. (2009). Diagnostic accuracy of vision screening tests for the detection of amblyopia and its risk factors: a systematic review. Graefe s Archive for Clinical and Experimental Ophthalmology. 247(11). 1441–1454. 17 indexed citations

18.

Woolacott, Nerys, Neil Hawkins, Anne Mason, et al.. (2006). Etanercept and efalizumab for the treatment of psoriasis: a systematic review. Health Technology Assessment. 10(46). 1–233, i. 200 indexed citations

19.

Collins, Rory, Rebecca Trowman, Gill Norman, et al.. (2006). A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer. British Journal of Cancer. 95(4). 457–462. 18 indexed citations

20.

Riemsma, Rob. (1998). Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support. British journal of rheumatology. 37(10). 1042–1046. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact